These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3291321)

  • 1. Cyclosporine therapy or dietary protein manipulation in chronic renal allograft rejection.
    Kootte AM; Paul LC
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):821-6. PubMed ID: 3291321
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine.
    Chapman JR; Morris PJ
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664
    [No Abstract]   [Full Text] [Related]  

  • 3. Improvement of renal function after conversion from cyclosporine only to prednisolone-azathioprine followed by late-onset graft failure in renal transplant patients.
    Tegzess AM; van Son WJ; Beelen JM; Sluiter WJ; Meijer S; Slooff MJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2000-4. PubMed ID: 3547904
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of cyclosporine in cadaveric renal transplantation in China.
    Xie T; Xu QJ
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):99-101. PubMed ID: 3291336
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporine experience in renal transplantation in children.
    Tejani A; Butt KM; Khawar MR; Hong JH; Fusi M; Pomrantz A
    Mt Sinai J Med; 1987 Sep; 54(6):467-74. PubMed ID: 3317018
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic renal allograft rejection and cyclosporine.
    Rowe PA; Foster MC; Richardson RE; Morgan AG; Burden RP
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):7-8. PubMed ID: 3051594
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclosporine levels are not helpful.
    Henry ML; Bowers VD; Fanning WJ; Sommer BG; Ferguson RM
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):419-21. PubMed ID: 3284086
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporine and metabolites in blood from renal allograft recipients with nephrotoxicity, rejection, or good renal function: comparative high-performance liquid chromatography and monoclonal radioimmunoassay studies.
    Rosano TG; Pell MA; Freed BM; Dybas MT; Lempert N
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):330-8. PubMed ID: 3284076
    [No Abstract]   [Full Text] [Related]  

  • 9. "Cyclosporine-A nephrotoxicity in renal allograft recipients".
    Nix K; Plawecki HM
    J Nephrol Nurs; 1985; 2(5):220-2. PubMed ID: 3903104
    [No Abstract]   [Full Text] [Related]  

  • 10. B2-microglobulin and renal graft rejection: relationship to plasma creatinine during stable transplant function and graft rejection.
    Barnes RM; Alexander LC; West CR
    Transplant Proc; 1984 Dec; 16(6):1613-5. PubMed ID: 6390875
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of cyclosporine A in the treatment of acute renal allograft rejection.
    Gascon M; Donnelly S; Lowry RP
    Transplant Proc; 1987 Aug; 19(4):3481-5. PubMed ID: 3303519
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical and experimental studies with cyclosporine in renal transplantation.
    Kahan BD; van Buren CT; Flechner SM; Jarowenko M; Yasumura T; Rogers AJ; Yoshimura N; LeGrue S; Drath D; Kerman RH
    Surgery; 1985 Feb; 97(2):125-40. PubMed ID: 3881837
    [No Abstract]   [Full Text] [Related]  

  • 13. Morphological patterns in cyclosporine-treated renal transplant recipients.
    Mihatsch MJ; Thiel G; Basler V; Ryffel B; Landmann J; von Overbeck J; Zollinger HU
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):101-16. PubMed ID: 3895652
    [No Abstract]   [Full Text] [Related]  

  • 14. Pre-transplant hypertension: a major risk factor for chronic progressive renal allograft dysfunction?
    Frei U; Schindler R; Wieters D; Grouven U; Brunkhorst R; Koch KM
    Nephrol Dial Transplant; 1995; 10(7):1206-11. PubMed ID: 7478125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine in the first month posttransplant.
    Rolles K; Calne RY
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):55-8. PubMed ID: 3515695
    [No Abstract]   [Full Text] [Related]  

  • 16. Spontaneous improvement of renal function following renal allograft rupture associated with acute rejection.
    Chan TM; Kwok TF; Yap FH; Cheng IK
    Clin Transplant; 1995 Apr; 9(2):71-3. PubMed ID: 7599404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of delayed function in cyclosporine-treated cadaver kidney transplants.
    Belitsky P; MacDonald AS; Gajewski J; Boudreau J; Bitter-Suermann H; Cohen A
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2096-9. PubMed ID: 3547912
    [No Abstract]   [Full Text] [Related]  

  • 18. Stability of renal allograft recipients after conversion from cyclosporine to azathioprine.
    Carpenter CB; Milford EL; Kirkman RL; Strom TB; Lazarus JM; Tilney NL
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):261-5. PubMed ID: 3927537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hypertension, hyperlipidemia and cyclosporine A therapy on long-term renal allograft survival.
    Maeda H; Sakamoto K; Kashiwabara H; Hachisu T; Yamada H; Matsushita K; Yamada K; Yokoyama T
    Transplant Proc; 1996 Jun; 28(3):1633-4. PubMed ID: 8658816
    [No Abstract]   [Full Text] [Related]  

  • 20. Contrast-induced nephrotoxicity in renal allograft recipients.
    Ahuja TS; Niaz N; Agraharkar M
    Clin Nephrol; 2000 Jul; 54(1):11-4. PubMed ID: 10939751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.